Filipe Novais leads the Portuguese affiliate for Astellas during an exciting time for the company globally. With a new global CEO, Astellas is aiming to be at the forefront of healthcare changes to turn innovative science into value for patients. Novais has a lot on his plate both to achieve sustainable growth by pursuing innovative science and leveraging this across a variety of therapeutic areas with medical solutions that provide value for patients in Portugal. What were your priorities when you took on the role two years ago?
"Despite the size of the market in Portugal, the affiliate has to make the right decisions to keep our financial key performance indicators healthy."